Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

This study has been completed.
Information provided by (Responsible Party):
Gilead Sciences Identifier:
First received: May 13, 2002
Last updated: January 13, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2003
  Primary Completion Date: February 2003 (Final data collection date for primary outcome measure)